Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gallagher Neil Insider Profile
4 Followers
Gallagher Neil, President, Head of R&D at Syndax Pharmaceuticals, holds 85.09K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in Zymeworks (Ticker: ZYME). Most recently, Gallagher Neil Sold ― shares of Syndax Pharmaceuticals on Feb 12, 2025 for an estimated value of 71.58K.
Gallagher Neil has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gallagher Neil holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gallagher Neil
Gallagher Neil's Trading History
Syndax Pharmaceuticals
Feb 12, 2025
President, Head of R&D
Informative Sell
71.58K
$1.39M
Zymeworks
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Gallagher Neil's performance on stock
You May Also Like
Gallagher Neil insider profile FAQ
What is the percentage of profitable transactions made by Gallagher Neil?
The percentage of profitable transactions made by Gallagher Neil is ―.
What is the average return per transaction made by Gallagher Neil?
The average return per transaction made by Gallagher Neil is ―.
What stocks does Gallagher Neil hold?
Gallagher Neil holds: SNDX, ZYME stocks.
What was Gallagher Neil’s latest transaction?
Gallagher Neil latest transaction was an Informative Sell of $71.58K.
What was Gallagher Neil's most profitable transaction?
Gallagher Neil’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gallagher Neil's role in Syndax Pharmaceuticals?
Gallagher Neil's role in Syndax Pharmaceuticals is President, Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.